Ki-1+ anaplastic large cell lymphoma in a child with unpredictable clinical course

Pediatr Hematol Oncol. 2001 Mar;18(2):143-6. doi: 10.1080/088800101300002982.

Abstract

Ki-1+ anaplastic large cell lymphoma (Ki-1+ ALCL) is a subtype of non-Hodgkin lymphoma (NHL) with defined histopathological characteristics but with highly variable clinical presentation and outcome. Although in most of the patients the disease behaves as an intermediate- or high-grade lymphoma, some patients present with an indolent clinical course. Factors that determine the clinical behavior of this lymphoma have not yet been identified. A case is reported of a 13-year-old girl who initially presented with Ki-1+ ALCL but later developed recurrent localized cutaneous disease and followed a clinical course similar to that of a low-grade lymphoma.

Publication types

  • Case Reports

MeSH terms

  • Adolescent
  • Antineoplastic Combined Chemotherapy Protocols / administration & dosage
  • Diagnosis, Differential
  • Disease-Free Survival
  • Female
  • Humans
  • Lymphoma, Follicular / diagnosis
  • Lymphoma, Follicular / drug therapy
  • Lymphoma, Follicular / pathology
  • Lymphoma, Large-Cell, Anaplastic / diagnosis
  • Lymphoma, Large-Cell, Anaplastic / drug therapy
  • Lymphoma, Large-Cell, Anaplastic / pathology*
  • Neoplasm Invasiveness
  • Neoplasms, Second Primary / chemistry
  • Neoplasms, Second Primary / drug therapy
  • Neoplasms, Second Primary / pathology
  • Recurrence
  • Skin Neoplasms / chemistry
  • Skin Neoplasms / drug therapy
  • Skin Neoplasms / pathology